TOP STORIES

• REGULATORY Nichi-Iko’s Toyama Plant Gets Back Online as Suspension Order Lifted
  April 6, 2021

• REGULATORY Ex-PMDA Inspector Urges Improvements in Japanese Inspection Systems after GMP Scandals
  April 5, 2021

• BUSINESS Takeda/CSL-Led Alliance’s COVID-19 Plasma Therapy Fails in PIII
  April 5, 2021

• BUSINESS GSK Sees Promise in Antibody Therapy against Coronavirus Variants, Looking at Japan Rollout Too
  April 2, 2021

• BUSINESS Alinamin Aims for Growth via Retail Promotion, Full Entry into Asia: President
  April 2, 2021

• BUSINESS Sandoz Shooting for Top Foreign Player in Japan Generic Market by 2023
  April 1, 2021

• BUSINESS Japan Trials Get Underway for AstraZeneca’s COVID-19 Antibody Therapy
  April 1, 2021

• ORGANIZATION Generic Industry Group Requests Blanket Manufacturing Checkups for 39 Member Firms
  March 31, 2021

• BUSINESS Nafamostat Inhalation Drug Now in Clinic for COVID-19: Daiichi Sankyo
  March 31, 2021

• REGULATORY Japan Gives Up on Setting New Generic Target by March as Manufacturing Scandals Weigh
  March 30, 2021

• REGULATORY Japan to Wade Deeper into Generic Industry Revamp in New Pharma Vision, Due Out Summer
  March 29, 2021

• REGULATORY 35.6% of Pfizer Vaccine Recipients Developed Fevers after 2nd Shot, Higher Incidence in Women: MHLW
  March 29, 2021

• REGULATORY Nichi-Iko Starting Marketing Operations from March 29
  March 29, 2021

• ORGANIZATION Industry Group Poised for Pilot Rollout of E-Labeling App in April, Looks to Sales Reps for Popularization
  March 26, 2021

• BUSINESS Astellas Sees Growth Potential for “Rx+” as Future Bread-and-Butter Biz: EVP
  March 26, 2021

• REGULATORY Chuikyo OKs Appraisal Results for Kymriah, Trelegy; Downward Price Tweaks Expected
  March 25, 2021

• REGULATORY Nichi-Iko Plant Probed before Lifting of Biz Suspension Order
  March 25, 2021

• REGULATORY Japan Approves Incyte’s Pemazyre, Bayer’s Vitrakvi, Novartis’ Kesimpta, and More
  March 24, 2021

• REGULATORY Appraisal Results for Kymriah, Trelegy Up for Chuikyo Review on March 24; Price Cuts Likely
  March 23, 2021

• BUSINESS Japan Approves 3rd CAR-T Cell Therapy, Celgene’s Breyanzi
  March 23, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 96
• 97
• 98
• 99
• 100
• 101
• 102
• 103
• 104
• …
• Next ›
• 最終 »